JPMorgan Chase & Co. Sells 155,406 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
JPMorgan Chase & Co. reduced its position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 12.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,141,505 shares of the company’s stock after selling 155,406 shares during the quarter. JPMorgan […]
JPMorgan Chase & Co. reduced its position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 12.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,141,505 shares of the company’s stock after selling 155,406 shares during the quarter. JPMorgan […]